Regardless of the specific screening option chosen, what is clear is that the inclusion of NT measurements optimizes Down syndrome screening.
The aim of the "FASTER" (First and Second Trimester Evaluation of Risk) study was slightly different: to compare first- and second-trimester testing for Down syndrome.1 The first-trimester approach was the same as the BUN trial, but results were withheld from a patient until second-trimester serum analyte results were available-unless the NT measurement was extremely elevated and the fetus had a cystic hygroma. More than 38,000 women from around the country participated in FASTER. The study found that both first- and second-trimester screening could detect around 85% of fetuses with Down syndrome, but that the screen-positive rate to achieve this detection efficiency was one third lower with first-trimester screening (see Table). They also noted that combining first- and second-trimester testing could yield even better results. A stepwise integrated approach provides patients the results of the first-trimester screen so they have the option of a CVS. It then combines the results of first- and second-trimester screening to produce a final risk assessment. This approach detected 95% of Down syndrome fetuses, for an overall 4.9% screen-positive rate.
Thus, patients now have a menu of options for Down syndrome screening. The advantages of first-trimester screening were articulated in an editorial accompanying the FASTER publication by Contemporary OB/GYN's long-term Editorial Board member Dr. Joe Leigh Simpson.3 He pointed out that earlier detection of increased Down syndrome risk permitted CVS, which is quite safe in experienced hands, as well as earlier terminations for patients who chose to abort affected pregnancies. Such earlier terminations are more private and safer. Thus, use of either first-trimester screening alone or the stepwise integrated option may well be the optimal approach.
Link between infertility and autism spectrum disorder risk
December 6th 2023New research uncovers a connection between infertility and autism spectrum disorder risk, prompting a closer look at perinatal influences and the potential impact of fertility treatments on the developmental trajectory of children.
Read More
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
Late-preterm antenatal corticosteroid treatment in twin pregnancies and newborn morbidity
November 27th 2023A recent retrospective cohort study found that administering antenatal corticosteroids from 34 to 36 weeks of gestation did not decrease composite neonatal respiratory morbidity in twin pregnancies, challenging conventional practices for this high-risk population.
Read More
The impact of WIC enrollment on breastfeeding rates: A comprehensive study
November 21st 2023Explore the findings of a recent study, revealing that enrollment in the Special Supplemental Nutritional Program for Women, Infants, and Children may influence breastfeeding decisions, shedding light on disparities and suggesting the need for targeted initiatives to enhance breastfeeding rates among low-income mothers.
Read More